The United States is the last country in the world with modern healthcare to adopt ICD-10 diagnosis codes, but it will join the crowd on Oct. 1, 2014. This massive ICD-10 change is quickly approaching, and it affects all of us in the health care field. Thus, there is no...
Prostate cancer is the most common cancer in men, currently affecting around 3 million American survivors, with another 180,000 men diagnosed each year. After prostate cancer treatment, prostate-specific antigen (PSA) testing...
If you are attending the National Cancer Registrars Association's (NCRA) 43rd Annual Conference in Washington, D.C., April 5-8, make sure to hear the keynote address on April 6 featuring Larry N. Shulman, MD Chair, Commission on Cancer. Stop by the American College of Surgeons...
Register today for the National Accreditation Program for Breast Centers (NAPBC) Accreditation Workshop: Pursuing Excellence through NAPBC Accreditation in Chicago on May 5. Designed for centers seeking accreditation for the first time and centers seeking re-accreditation,...
The treatment landscape of head and neck cancer has changed significantly over the past year. With the approval of Keytruda (pembrolizumab) in August 2016 and Opdivo (nivolumab) in November 2016, immunotherapy has become a key player in patient care.
A shared decision-making visit was associated with better understanding of the eligibility, harms and benefits in patients considering lung cancer screening with low-dose CT, according to a study published in Chest. "We found...
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario recently issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer. The update provides...
Subscribe to The Brief
|State / Province:|
|Zip / Postal Code:|
|Do you work for a CoC or NAPBC Accredited Program?||Yes No|